塞力医疗：8月27日召开董事会会议

Core Viewpoint - Seer Medical (SH 603716) announced the convening of its 20th meeting of the 5th Board of Directors on August 27, 2025, to review the semi-annual report for 2025 and its summary [1] Group 1: Company Financials - For the year 2024, Seer Medical's revenue composition is as follows: commercial revenue accounts for 97.09%, while industrial revenue makes up 2.91% [1]